Clinical and imaging features of myeloid sarcoma: a German multicenter study

Abstract

BackgroundMyeloid sarcoma (MS), also known as chloroma, is an extramedullary manifestation of malignant primitive myeloid cells. Previously, only small studies investigated clinical and imaging features of MS. The purpose of this study was to elucidate clinical and imaging features of MS based upon a multicenter patient sample.MethodsPatient records of radiological databases of 4 German university hospitals were retrospectively screened for MS in the time period 01/2001 and 06/2019. Overall, 151 cases/76 females (50.3%) with a mean age of 55.5 ± 15.1 years and 183 histopathological confirmation or clinically suspicious lesions of MS were included into this study. The underlying hematological disease, localizations, and clinical symptoms as well as imaging features on CT and MRI were investigated.ResultsIn 15 patients (9.9% of all 151 cases) the manifestation of MS preceded the systemic hematological disease. In 43 cases (28.4%), first presentation of MS occurred simultaneously with the initial diagnosis of leukemia, and 92 (60.9%) patients presented MS after the initial diagnosis. In 37 patients (24.5%), the diagnosis was made incidentally by imaging. Clinically, cutaneous lesions were detected in 35 of 151 cases (23.2%). Other leading symptoms were pain (n = 28/151, 18.5%), neurological deficit (n = 27/151, 17.9%), swelling (n = 14/151, 9.3%) and dysfunction of the affected organ (n = 10/151, 6.0%). Most commonly, skin was affected (n = 30/151, 16.6%), followed by bone (n = 29/151, 16.0%) and lymphatic tissue (n = 21/151, 11.4%). Other localizations were rare. On CT, most lesions were homogenous. On T2-weighted imaging, most of the lesions were hyperintense. On T1-weighted images, MS was hypointense in n = 22/54 (40.7%) and isointense in n = 30/54 (55.6%). A diffusion restriction was identified in most cases with a mean ADC value of 0.76 ± 0.19 × 10− 3 mm2/s.ConclusionsThe present study shows clinical and imaging features of MS based upon a large patient sample in a multicenter design. MS occurs in most cases meta-chronous to the hematological disease and most commonly affects the cutis. One fourth of cases were identified incidentally on imaging, which needs awareness of the radiologists for possible diagnosis of MS.

Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years Experience

“…2 The most common locations include soft tissue, bone, gastrointestinal tract, and lymph nodes; the affection of the central nervous system is rare, with a reported frequency of 1.5%, which can have a crucial impact on the clinical course of the disease. 10 The overall incidence of EMI in our study is 11% but drops to 7% if considered at AML diagnosis. The appearance of EMI in the course of AML is a complex phenomenon, and it is associated with a series of clinical and laboratory characteristics, such as high levels of lactate-dehydrogenases (LDH) and leukocytosis.…”

“… 2 The most common locations include soft tissue, bone, gastrointestinal tract, and lymph nodes; the affection of the central nervous system is rare, with a reported frequency of 1.5%, which can have a crucial impact on the clinical course of the disease. 10 …”

Clinical characteristics and management of primary granulocytic sarcoma of the oral cavity

“…In addition, imaging changes that present as soft tissue-occupying lesions, with or without bone erosions, are atypical. [ 42 – 43 ] Therefore, it is usually misdiagnosed as a dental ulcer, epulis and gingival hyperplasia, as well as malignant neoplasms. The challenge to dental practitioners is in differentiating malignant, infectious, and inflammatory lesions, which can often have overlapping clinical features.…”

Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche

“…Migration of myeloid cells to extramedullary tissue involves signaling pathways that have not been clearly defined [6]. Extramedullary AML has been described in 26 different anatomic locations, though the kidney is a rare site even amongst cases of extramedullary AML [8]. Multiple factors have correlated with the presence of extramedullary AML, including karyotypic changes such as inv( 16), cell surface markers such as CD56 and CD7, M4 and M5 subtypes of the FAB classification [7].…”